Solitaire Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 03-07-2024
- Paid Up Capital ₹ 0.10 M
as on 03-07-2024
- Company Age 12 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -3.74%
(FY 2022)
- Profit 39.11%
(FY 2022)
- Ebitda 74.94%
(FY 2022)
- Net Worth -24.20%
(FY 2022)
- Total Assets 14.73%
(FY 2022)
About Solitaire Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vivek Kadam, Romit Jain, and Pranay Jain serve as directors at the Company.
- CIN/LLPIN
U74999MH2012PTC235969
- Company No.
235969
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Sep 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Solitaire Healthcare Private Limited offer?
Solitaire Healthcare Private Limited offers a wide range of products and services, including Vitamin Tablets & Capsules, Evion Vitamin Capsule Supplement, Calcium Tablet, Calcium & Vitamin D3 Tablet, Nutraceuticals & Dietary Supplements, Mineral Supplement, Antipyretic Medication, Paracetamol Tablets.
Who are the key members and board of directors at Solitaire Healthcare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Romit Jain  | Director | 20-Sep-2012 | Current |
| Pranay Jain | Director | 20-Sep-2012 | Current |
| Vivek Kadam | Director | 10-Mar-2017 | Current |
Financial Performance of Solitaire Healthcare.
Solitaire Healthcare Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 3.74% decrease. The company also saw a substantial improvement in profitability, with a 39.11% increase in profit. The company's net worth observed a substantial decline by a decrease of 24.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Solitaire Healthcare?
In 2021, Solitaire Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Solitaire Healthcare?
Unlock and access historical data on people associated with Solitaire Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Solitaire Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Solitaire Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
